Literature DB >> 22133765

Multiple sclerosis: is prevalence rising and if so why?

Julián Benito-León1.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 22133765      PMCID： PMC3251240          DOI： 10.1159/000334606

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN： 0251-5350            Impact factor:   3.282


× No keyword cloud information.
  23 in total

1.  Increasing prevalence and incidence of multiple sclerosis in northern Japan.

Authors:  H Houzen; M Niino; D Hata; F Nakano; S Kikuchi; T Fukazawa; H Sasaki
Journal:  Mult Scler       Date:  2008-06-23       Impact factor: 6.312

2.  Geographic distribution of multiple sclerosis: An update with special reference to Europe and the Mediterranean region.

Authors:  J F Kurtzke
Journal:  Acta Neurol Scand       Date:  1980-08       Impact factor: 3.209

3.  Multiple sclerosis in the Turkish- and Greek-speaking communities of Cyprus. A United Nations (UNHCR) Bicommunal Project.

Authors:  G Dean; H Aksoy; T Akalin; L Middleton; K Kyriallis
Journal:  J Neurol Sci       Date:  1997-02-12       Impact factor: 3.181

Review 4.  Quality of life and its assessment in multiple sclerosis: integrating physical and psychological components of wellbeing.

Authors:  Alex J Mitchell; Julián Benito-León; José-Manuel Morales González; Jesús Rivera-Navarro
Journal:  Lancet Neurol       Date:  2005-09       Impact factor: 44.182

5.  Prevalence and incidence of multiple sclerosis in western Greece: a 23-year survey.

Authors:  Panagiotis Papathanasopoulos; Efthimia Gourzoulidou; Lambros Messinis; Vasillis Georgiou; Michalis Leotsinidis
Journal:  Neuroepidemiology       Date:  2008-04-02       Impact factor: 3.282

6.  Multiple sclerosis in Móstoles, central Spain.

Authors:  J Benito-León; E Martin; L Vela; M E Villar; B Felgueroso; C Marrero; A Guerrero; J Ruiz-Galiana
Journal:  Acta Neurol Scand       Date:  1998-10       Impact factor: 3.209

7.  Contribution of incidence to increasing prevalence of multiple sclerosis in Alberta, Canada.

Authors:  S A Warren; L W Svenson; K G Warren
Journal:  Mult Scler       Date:  2008-06-23       Impact factor: 6.312

8.  A systematic approach to analyse health-related quality of life in multiple sclerosis: the GEDMA study.

Authors:  J M Morales-Gonzáles; J Benito-León; J Rivera-Navarro; A J Mitchell
Journal:  Mult Scler       Date:  2004-02       Impact factor: 6.312

9.  Increasing prevalence and incidence of multiple sclerosis in South East Wales.

Authors:  C Hirst; G Ingram; T Pickersgill; R Swingler; D A S Compston; N P Robertson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2008-10-17       Impact factor: 10.154

Review 10.  A review about the impact of multiple sclerosis on health-related quality of life.

Authors:  Julián Benito-León; José Manuel Morales; Jesús Rivera-Navarro; Alex Mitchell
Journal:  Disabil Rehabil       Date:  2003-12-02       Impact factor: 3.033
View more
  8 in total

1.  Multiple sclerosis in the Republic of San Marino, Italian peninsula: an incidence and prevalence study from a high-risk area.

Authors:  Marta Caniglia-Tenaglia; Susanna Guttmann; Chiara Monaldini; Dario Manzaroli; Mirco Volpini; Maurizio Stumpo; Elisabetta Groppo; Ilaria Casetta; Vittorio Govoni; Mattia Fonderico; Maura Pugliatti; Enrico Granieri
Journal:  Neurol Sci       Date:  2018-04-18       Impact factor: 3.307

2.  Validity and Reliability of the Turkish Version of the Monitoring My Multiple Sclerosis Scale.

Authors:  Cansu Polat; Zeliha Tülek; Murat Kürtüncü; Mefkure Eraksoy
Journal:  Noro Psikiyatr Ars       Date:  2017-01-19       Impact factor: 1.339

Review 3.  Proteomics in Multiple Sclerosis: The Perspective of the Clinician.

Authors:  Dániel Sandi; Zsófia Kokas; Tamás Biernacki; Krisztina Bencsik; Péter Klivényi; László Vécsei
Journal:  Int J Mol Sci       Date:  2022-05-05       Impact factor: 6.208

Review 4.  A systematic review of randomized, double-blind, placebo-controlled trials examining the clinical efficacy of vitamin D in multiple sclerosis.

Authors:  Beatriz Pozuelo-Moyano; Julián Benito-León; Alex J Mitchell; Jesús Hernández-Gallego
Journal:  Neuroepidemiology       Date:  2012-12-18       Impact factor: 3.282

5.  Understanding tremor in multiple sclerosis: prevalence, pathological anatomy, and pharmacological and surgical approaches to treatment.

Authors:  Andrés Labiano-Fontcuberta; Julián Benito-León
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2012-09-14

Review 6.  Treatment adherence and other patient-reported outcomes as cost determinants in multiple sclerosis: a review of the literature.

Authors:  Luis Lizán; Marta Comellas; Silvia Paz; José Luis Poveda; Dennis M Meletiche; Carlos Polanco
Journal:  Patient Prefer Adherence       Date:  2014-12-04       Impact factor: 2.711

7.  Resource utilization, costs and treatment patterns of switching and discontinuing treatment of MS patients with high relapse activity.

Authors:  Karina Raimundo; Haijun Tian; Huanxue Zhou; Xin Zhang; Kristijan H Kahler; Neetu Agashivala; Edward Kim
Journal:  BMC Health Serv Res       Date:  2013-04-08       Impact factor: 2.655

8.  Epidemiology of multiple sclerosis in Central Europe, update from Hungary.

Authors:  Tamás Biernacki; Dániel Sandi; Zsanett Fricska-Nagy; Zsigmond Tamás Kincses; Judit Füvesi; Rózsa Laczkó; Zsófia Kokas; Péter Klivényi; László Vécsei; Krisztina Bencsik
Journal:  Brain Behav       Date:  2020-03-20       Impact factor: 2.708
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.